Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dian Sheng

Showing results (71-80 of 71) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 71 results.
CA: a Cancer Journal for Clinicians|March 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 studyJian-Chun Duan, Jia Zhong, Bo-Yang Sun, et al.
Pageof 8

Showing results (71-80 of 71) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 71 results.
CA: a Cancer Journal for Clinicians|March 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 studyJian-Chun Duan, Jia Zhong, Bo-Yang Sun, et al.
Pageof 8